Vectopia

Vectopia is a Swiss biotech spin-off from the University of Geneva that specializes in the development of innovative manufacturing solutions for gene therapy. The company's core technology focuses on streamlining the production of lentiviral vectors, which are essential vehicles used to deliver therapeutic genes into a patients cells. By simplifying and scaling the manufacturing process, Vectopia addresses a major industry bottleneck the high cost and complexity of production with the ultimate goal of making life-saving gene treatments more affordable and accessible to a broader patient population.